Back to results
US 2026/0256737 A1Published application
Compositions for pathogenesis-directed therapy and treatments of skin diseases and disorders
AssigneeYale University
InventorsKeith Choate, Lihi R. Atzmony
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising at least one lipid-lowering drug or a derivative thereof for the treatment of skin diseases or disorders. In various aspects of the invention, the composition further comprises at least one lipid or a derivative thereof.
Claims17
1-34. (canceled)
A method of treating porokeratosis, the method comprising topically administering a therapeutically effective amount of a composition to a subject in need thereof,
- wherein the composition comprises a 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitor,
- wherein the porokeratosis is one selected from the group consisting of plaque-type porokeratosis (porokeratosis of Mibelli), disseminated superficial actinic porokeratosis (DSAP), disseminated superficial porokeratosis (DSP), porokeratosis palmaris et plantaris disseminate (PPPD), linear porokeratos (LP), punctate porokeratosis, porokeratosis plantaris discrete, porokeratosis ptychotropica, porokeratoma, solar facial porokeratosis, hyperkeratotic porokeratosis, and any combination thereof, and
- wherein the porokeratosis in the subject is treated.
Dependencies are inferred from the claim text.